Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes
Authors:
- Christopher MillettCMChristopher Millett
- Jeremy GrayJGJeremy Gray
- Sonia SaxenaSSSonia Saxena
- Gopalakrishnan NetuveliGNGopalakrishnan Netuveli
- Azeem MajeedAMAzeem Majeed
Open Access
- 5 June 2007
- journal article
- research article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 176 (12) , 1705-1710
Abstract
Background: Many people with diabetes continue to smoke despite being at high risk of cardiovascular disease. We examined the impact of a pay-for-performance incentive in the United Kingdom introduced in 2004 as part of the new general practitioner contract to improve support for smoking cessation and to reduce the prevalence of smoking among people with chronic diseases such as diabetes. Methods: We performed a population-based longitudinal study of the recorded delivery of cessation advice and the prevalence of smoking using electronic records of patients with diabetes obtained from participating general practices. The survey was carried out in an ethnically diverse part of southwest London before (June–October 2003) and after (November 2005–January 2006) the introduction of a pay-for-performance incentive. Results: Significantly more patients with diabetes had their smoking status ever recorded in 2005 than in 2003 (98.8% v. 90.0%, p p < 0.001). The prevalence of smoking decreased significantly from 20.0% to 16.2% (p < 0.001). The reduction over the study period was lower among women (adjusted odds ratio 0.71, 95% confidence interval 0.53–0.95) but was not significantly different in the most and least affluent groups. In 2005, smoking rates continued to differ significantly with age (10.6%–25.1%), sex (women, 11.5%; men, 20.6%) and ethnic background (4.9%–24.9%). Interpretation: The introduction of a pay-for-performance incentive in the United Kingdom increased the provision of support for smoking cessation and was associated with a reduction in smoking prevalence among patients with diabetes in primary health care settings. Health care planners in other countries may wish to consider introducing similar incentive schemes for primary care physicians.Keywords
This publication has 17 references indexed in Scilit:
- National Institutes of Health State-of-the-Science Conference Statement: Tobacco Use: Prevention, Cessation, and ControlAnnals of Internal Medicine, 2006
- The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003Diabetic Medicine, 2005
- General practitioners’ and family physicians’ negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic reviewAddiction, 2005
- Preventing cardiovascular events in patients with diabetes mellitusThe American Journal of Medicine, 2004
- Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registersBMJ, 2003
- Impact of patient characteristics on physician’s smoking cessation strategiesPreventive Medicine, 2003
- Discussion of NRT and other antismoking interventions in UK general practitioners' routine consultationsNicotine & Tobacco Research, 2003
- Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings.Diabetes Care, 2000
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- Trends in Cigarette Smoking and Physicians' Advice to Quit Smoking Among People with Diabetes in the U.S.Diabetes Care, 1995